Onderneming Jazz Pharmaceuticals, Inc. Nasdaq
Aandelen
US4721471070
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
|
10/07 | Jazz Pharmaceuticals plc bevordert Samantha Pearce tot Chief Commercial Officer | CI |
20/06 | JAZZ PHARMACEUTICALS PLC : Needham & Co. handhaaft koopadvies | ZM |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 3 659 | 100,0 % | 3 834 | 100,0 % | +4,78% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
91,0
%
| 3 370 | 92,1 % | 3 490 | 91,0 % | +3,55% |
Europe
7,0
%
| 240 | 6,5 % | 269 | 7,0 % | +12,35% |
All Other
2,0
%
| 49 | 1,3 % | 75 | 2,0 % | +51,92% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01-03-03 |
Renée Galá
PSD | President | 52 | 16-03-20 |
Robert Iannone
CTO | Chief Tech/Sci/R&D Officer | 57 | 29-05-19 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18-01-12 |
Andrea N. Flynn
IRC | Investor Relations Contact | - | - |
Shawn Mindus
PRN | Corporate Officer/Principal | - | - |
John Miller
PRN | Corporate Officer/Principal | - | - |
Heidi Manna
HRO | Human Resources Officer | 53 | 01-11-18 |
Neena Patil
LAW | General Counsel | 49 | 01-07-19 |
Aislinn Doody
SEC | Corporate Secretary | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Cozadd
CEO | Chief Executive Officer | 60 | 01-03-03 |
Norbert Riedel
BRD | Director/Board Member | 66 | 13-05-13 |
Patrick Enright
BRD | Director/Board Member | 62 | 01-01-09 |
Peter Gray
BRD | Director/Board Member | 69 | 08-05-13 |
Ken O'Keefe
BRD | Director/Board Member | 57 | 01-01-04 |
Rick Winningham
BRD | Director/Board Member | 64 | 01-01-10 |
Seamus Mulligan
BRD | Director/Board Member | 63 | 18-01-12 |
Heather McSharry
BRD | Director/Board Member | 62 | 02-05-13 |
Catherine Sohn
BRD | Director/Board Member | 71 | 27-07-12 |
Anne O’Riordan
BRD | Director/Board Member | 56 | 14-02-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 63 062 356 | 61 308 189 ( 97,22 %) | 0 | 97,22 % |
Bedrijfsgegevens
Jazz Pharmaceuticals Plc
Waterloo Exchange Waterloo Road
4, Dublin
+353 1 634 7800
http://www.jazzpharmaceuticals.com![Adres Jazz Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/52352.png)
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Jazz Securities DAC
|
Finance/Rental/Leasing
|
Jazz Investments II Ltd.
|
Finance/Rental/Leasing
|
Jazz Financing Holdings Ltd.
![]() Jazz Financing Holdings Ltd. MiscellaneousMiscellaneous Part of Jazz Pharmaceuticals Plc, Jazz Financing Holdings Ltd. is an investment holding Irish company. The company is located in Ireland. |
Miscellaneous
|
Jazz Investments Europe Ltd.
| |
Jazz Pharmaceuticals Ireland Ltd.
![]() Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. |
Pharmaceuticals: Major
|
Jazz Financing I DAC
|
Finance/Rental/Leasing
|
Jazz Pharmaceuticals Ireland Holdings Ltd.
| |
Jazz Financing Lux SARL
![]() Jazz Financing Lux SARL Finance/Rental/LeasingFinance Part of Jazz Pharmaceuticals Plc, Jazz Financing Lux SARL provides financing services. The company is based in Luxembourg, Luxembourg. Founded in 2013. |
Finance/Rental/Leasing
|
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+61,53% | 856 mld. | |
+38,95% | 631 mld. | |
-3,66% | 359 mld. | |
+15,06% | 325 mld. | |
+9,18% | 297 mld. | |
+5,89% | 234 mld. | |
+16,53% | 226 mld. | |
+15,67% | 177 mld. | |
+2,47% | 165 mld. |
- Beurs
- Aandelen
- Koers JAZZ
- Koers
- Onderneming Jazz Pharmaceuticals, Inc.